02/09/2024
2:06 PM | Galecto (Subject)
Otto Erik (Filed by)
| Form SCHEDULE 13G/A | |
12/21/2023
3:30 PM | Galecto (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
8:00 AM | Galecto (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
10:29 AM | Galecto (Subject)
Otto Erik (Filed by)
| Form SC 13G | |
10/02/2023
8:55 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
8:49 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
8:50 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/02/2023
8:53 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023
3:00 PM | Galecto (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:19 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
09/05/2023
3:20 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
08/30/2023
4:02 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023
4:08 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2023
4:17 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
7:14 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144/A | |
08/21/2023
3:55 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
3:57 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
3:39 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2023
3:47 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
3:40 PM | Galecto (Issuer)
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:30 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
08/15/2023
5:22 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:25 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:29 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
5:19 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
7:00 AM | Galecto (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2023
5:29 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023
5:31 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023
5:36 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023
5:38 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2023
3:00 PM | Galecto (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023
3:11 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
07/17/2023
3:13 PM | Galecto (Issuer)
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:07 PM | Galecto (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
7:09 PM | Galecto (Subject)
OrbiMed Advisors Israel II Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
7:00 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023
7:04 PM | Galecto (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
